Nūhou

NUI IOKA, Iune 23, 2022 (GLOBE NEWSWIRE) — Hoʻolaha ʻo Reportlinker.com i ka hoʻokuʻu ʻia ʻana o ka hōʻike "Global Intravenous Therapy and Intravenous Access Market Size, Share and Industry Trends Analysis Report, Outlook and Forecast by End User, Application, Type, Region, 2022-2028″ – https://www.reportlinker.com/p06283441/?utm_source=GNW ʻO ke ala wikiwiki loa e hoʻokomo i nā wai i loko o nā ʻāpana like ʻole o ke kino ma o ka IV therapy. Hoʻōla ʻia ka hōʻeha puʻuwai, ka hahau, a me ka lāʻau make me kēia lāʻau. I kēia hihia, pono e mālama ʻia ka mea maʻi me ka lāʻau i ka wā hikiwawe loa, no laila e hāʻawi ana i ka lāʻau intravenously. Hāʻawi ʻia nā lāʻau lapaʻau Chemotherapy, antibiotics, antifungals, pain relievers, immune globulin treatments, a me nā lāʻau koko koko. ʻO ka Intravenous therapy (IV) kahi ʻano o ka hāʻawi ʻana i nā lāʻau lapaʻau a me nā wai i loko o ke kino ma o kahi vein. Hāʻawi ʻia nā lāʻau lapaʻau e loaʻa ana nā huaora a me nā minelala e ka intravenous drip a i ʻole ka intravenous injection, e ʻae ana i ka lāʻau e holo wikiwiki ma o ke kahe koko. Wahi a Scope, ʻo ka hoʻokele IV ka wā e hoʻohana ai ka mea maʻi i kahi paipu i kapa ʻia he cannula e kau pololei i nā mea i loko o kahi vein. Hiki paha kēia i kahi hopena ʻaoʻao o ka lāʻau lapaʻau a i ʻole ka nele i ka meaʻai. ʻO ka IV therapy ke ala maʻamau e hāʻawi ai i nā wai, nā lāʻau lapaʻau, chemotherapy, a me nā hoʻoili koko i nā poʻe maʻi dehydrated. I ka wā o ka hoʻokele IV, hoʻohana ʻia nā lako IV like ʻole e like me nā catheters IV, nā pamu infusion, nā mea hoʻopaʻa, a me nā pahu hoʻokele. He wikiwiki ka hoʻokele IV therapy, maʻalahi ke hahai, a ʻaʻohe hopena ʻaoʻao gastrointestinal. Hoʻolaha ia i ka pane wikiwiki o ka ʻōnaehana pale a hōʻoluʻolu i nā maʻi maʻi ma mua o ka hoʻokele waha. Loaʻa iā ia kahi pamu infusion e kāohi ana i ka nui o nā kemika e hoʻolako ʻia i ke kino a hiki ke nānā maʻalahi ʻia. Manaʻo ʻia e hoʻonui ʻia ka mākeke intravenous therapy honua a me nā mea komo intravenous i ka wā wānana. ʻO ka nui o ka maʻi diabetes, ka piʻi ʻana o nā ulia kaʻa, a me ka hoʻonui ʻana i nā kaʻina hana ʻoki e manaʻo ʻia e hoʻoneʻe i ka ʻoihana i mua. Hoʻokele ʻia ka ʻoihana e ka ulu ʻana o ke koi no nā ʻano hana akamai, e like me ka lawe ʻana i ka lāʻau lapaʻau me ka ʻole o ka nila. Hopena COVID-19 He hopena maikaʻi ko COVID-19 ma ka mākeke IV therapy. I nā poʻe maʻi me ka pilikia hanu koʻikoʻi e pili ana i ka COVID-19. ʻO ka maʻi maʻi, ua lawelawe ʻia ka IV therapy (ARDS). No ka laʻana, ʻo ka hoʻohana ʻana i ka intravenous immune globulin no ka mālama ʻana i ka COVID-19 ARDS ma ke ʻano he adjuvant hoihoi no ka mālama ʻana i ka ARDS pili COVID-19 koʻikoʻi i paʻi ʻia ma The Lancet Respiratory Medicine ma Nowemapa 11, 2021 no ka mea hiki ke hoʻololi i nā ʻāpana pale he nui i ka manawa like. No laila, me ka hoʻonui ʻia o ka nui o nā maʻi me ka ARDS pili COVID-19, piʻi ka noi no ka IV therapy a me nā huahana komo intravenous. Nā kumu ulu mākeke e hoʻonui ana i nā hana a me ka ulu ʻana o ka heluna kanaka Geriatric Ua hoʻonui ʻia ka nui o nā maʻi maʻi like ʻole e pono ai ka vascular access therapy i nā makahiki he ʻumi i hala. ʻO nā maʻi maʻi e like me ke kanesa, ka hāʻule ʻana o ka puʻupaʻa a me ka maʻi puʻuwai, a me nā ʻano nohona like ʻole e like me ke koko kiʻekiʻe, ka maʻi diabetes, ka momona a me ke kaumaha, pono ka mālama koʻikoʻi i ka wā e noho ana i ka haukapila. I nā makahiki e hiki mai ana, ʻo ka hoʻonui ʻana o ke kaumaha o nā maʻi maʻi e like me ka maʻi cardiovascular, ke kanesa, ka hahau, a me ka maʻi diabetes, me ka heluna kanaka ʻelemakule, e hoʻonui i ka pono no ka intravenous therapy. Nā holomua ʻenehana ʻO nā catheters intravenous (peripheral a me ke kikowaena), nā mea pono me nā mea palekana, a me nā pamu infusion tip kekahi o nā ʻenehana nā kumuwaiwai e hāʻawi i ka hana palekana a kiʻekiʻe hoʻi o ka intravenous therapy (IVT). ʻOiai he ʻano paʻakikī ka ʻenehana olakino, me ka noʻonoʻo a me ke kūkākūkā ʻana i kēlā me kēia lā e nā loea olakino e pili ana i ka mālama ʻana i ka mea maʻi ma ka ʻāpana mālama koʻikoʻi, ua loli nui ke kahua o ka mālama ʻana ma muli o ka hoʻohui ʻana o nā ʻenehana hou, a ʻo nā pamu infusion ʻoi loa kekahi o nā kumuwaiwai loea e kōkua i ka hoʻokō ʻana i ka hana intravenous therapy (IVT) palekana a kiʻekiʻe hoʻi. Nā Palena o ka Mākeke Pono ka hana ʻana o ka pamu i nā lula koʻikoʻi a me nā hopohopo e pili ana i nā pilikia. Ke alakaʻi ʻia nei ke kaʻina hana laikini no nā papahana hou a puni ka hana ʻana o ka pamu a me ka hoʻopaʻa ʻana. Eia kekahi, ʻo ka piʻi ʻana o nā hoʻomanaʻo huahana ma muli o nā hemahema hana e hoʻolohi i ka hoʻohana ʻana i kēia mau therapies. No ka laʻana, ua hoʻomanaʻo ʻo Fresenius Kabi i ka Vigilant Agilia Drug Depot a me Volumat MC Agilia Infusion Pump i ʻAukake 2019 ma muli o nā pilikia hoʻomaopopo infusion, Keep Vein Open (KVO) haʻahaʻa haʻahaʻa a me nā hewa polokalamu ʻē aʻe. ʻO kahi keakea nui i ka ulu ʻana o ka ʻoihana ʻo ia nā pilikia e pili ana i ka hoʻohana ʻana i nā ʻano IV a me nā huahana infusion IV. Nānā Mea Hoʻohana Hope Ma muli o ka mea hoʻohana hope, ua māhele ʻia ka mākeke i nā haukapila, ke ʻoki kino ambulatory nā kikowaena, a me nā keʻena lapaʻau. E hopu ka ʻāpana haukapila i ka hapa nui loa o ka loaʻa kālā ma ka mākeke mālama intravenous (IV) a me ke komo ʻana o venous i ka makahiki 2021. ʻO kēia ma muli o ka hoʻonui ʻia ʻana o ka nui o nā ʻokiʻoki i hana ʻia i hoʻohālikelike ʻia me nā kikowaena ʻokiʻoki ambulatory a me nā keʻena lapaʻau. Eia kekahi, ua pili ka ulu ʻana o ka ʻāpana i ka hoʻonui ʻia ʻana o ka hoʻohana ʻana i ka lāʻau lapaʻau intravenous i nā haukapila, ʻo ia hoʻi ka lāʻau lapaʻau antibiotic intravenous, nā lāʻau lapaʻau no nā maʻi comatose, nā lāʻau lapaʻau ʻaʻole hiki ke lawe waha ʻia, radiology interventional, nā lāʻau anticancer, hemodialysis, repeat blood sample mapping, a me nā hoʻoili koko. Ke ulu nei ka mākeke no ka lāʻau lapaʻau IV a me nā mea komo venous ma muli o ka holomua o ka ʻenehana a me nā hoʻopukapuka kālā haukapila. Nānā Noi Ma ke kumu o ka noi, ua māhele ʻia ka mākeke i ka hoʻokele lāʻau, nā huahana koko, nā meaʻai a me nā mea hoʻonā buffer, a me nā kīʻaha hoʻonui. I ka makahiki 2021, e loaʻa i ka ʻāpana Volume Expander ka hapa nui o ka loaʻa kālā ma ka mākeke lāʻau lapaʻau intravenous (IV) a me ke komo ʻana o venous. Hiki i nā wai intravenous ke lilo i mea pono no kahi helu liʻiliʻi o nā mea pāʻani wai-sensitive; akā naʻe, pono e mālama ʻia kēia no nā mea pāʻani kiʻekiʻe me ka mōʻaukala o nā hōʻailona ikaika ma lalo o ka nānā pono ʻana. Hiki i kekahi mau mea pāʻani ke pōmaikaʻi mai ka hoʻohana ʻana i kahi mea hoʻonui. Ua pāpā ʻia nā wai intravenous a me nā mea hoʻopaʻa plasma i nā hoʻokūkū i kāohi ʻia e WADA. No ka hapa nui o nā mea pāʻani, ʻaʻole ʻo ka lāʻau lapaʻau IV maʻamau ke koho maikaʻi loa. ʻAno Nānā Ma muli o ke ʻano, ua māhele ʻia ka mākeke i nā catheters intravenous, nā pamu infusion, nā nila hypodermic, nā awa implantable, a me nā mea ʻē aʻe. I ka makahiki 2021, e hopu ka ʻāpana catheter intravenous i ka hapa nui loa o ka loaʻa kālā ma ka lāʻau lapaʻau intravenous (IV) a me ka mākeke komo venous. ʻO kēia ma muli o ka hoʻonui ʻia o ka hoʻohana ʻana i nā catheters IV i ka wā o nā kaʻina hana no ka lāʻau lapaʻau IV a i ka wā o ka hoʻoili ʻana o ke koko, nā lāʻau lapaʻau, a me nā meaʻai ʻē aʻe i nā ʻāpana like ʻole o ke kino. ʻO nā catheters intravenous he mau paipu liʻiliʻi i kau ʻia i loko o kahi lua kino a i ʻole lumen. ʻO kahi catheter intravenous he catheter intravenous i hoʻohana ʻia e hāʻawi i nā lāʻau lapaʻau, nā wai, a i ʻole nā ​​​​​​lāʻau lapaʻau ʻē aʻe i loko o ke kahe koko. Hoʻokomo pinepine ʻia lākou i loko o kahi vein ma ka lima, ʻoiai hiki ke hoʻokomo ʻia i loko o ka ʻāʻī, ka umauma, a i ʻole ka ʻūhā. Hele mai nā catheters intravenous i nā ʻano nui a me nā ʻano like ʻole, ma muli o kā lākou hoʻohana i manaʻo ʻia. Nānā ʻĀpana Ma muli o ka ʻāina, ua māhele ʻia ka mākeke i ʻAmelika ʻĀkau, ʻEulopa, ʻAsia Pākīpika & ʻAmelika Latina, Hikina Waena & ʻApelika. I ka makahiki 2021, ʻo ʻAmelika ʻĀkau ka ʻāina alakaʻi i ka mākeke intravenous (IV) therapy a me ke komo ʻana o ka venous ma o ka hopu ʻana i ka hapa nui o ka loaʻa kālā mākeke. Hiki ke hoʻopili ʻia ka ulu ʻana o ka mākeke ʻāina i ka hoʻonui ʻia ʻana o ka nui o nā maʻi, ka piʻi ʻana o nā ulia kaʻa, ka ulu nui ʻana o nā hihia trauma, a me ka hoʻonui ʻana i nā hoʻopukapuka kālā pekelala i ka hoʻomohala ʻana i nā hale lapaʻau maikaʻi aʻe a me nā hana R&D. Uhi ka hōʻike noiʻi mākeke i ka nānā ʻana o nā mea kuleana koʻikoʻi o ka mākeke. ʻO nā hui nui i hōʻike ʻia ma ka hōʻike e pili ana iā B. Braun Melsungen AG, Medtronic PLC, Terumo Corporation, Fresenius SE & Co. KGaA, Cardinal Health, Inc., Pfizer, Inc., Teleflex, Inc., Baxter International, Inc., Smiths Group PLC a me AngioDynamics, Inc. Hoʻolaha i nā hoʻolālā ma ka mākeke Intravenous (IV) Therapy a me Intravenous Access Malaki 2022: Ua kau inoa ʻo Fresenius Kabi i kahi ʻaelike e loaʻa iā Fresenius Kabi, kahi hui mālama ola honua. ʻO ka loaʻa ʻana, i hoʻolālā ʻia e hoʻohui i nā ʻōnaehana infusion i hoʻonui ʻia ʻo Ivenix i loko o ka waihona o Fresenius Kabi o ka infusion intravenous a me ʻO nā huahana hoʻōla infusion, e lawe mai i kahi hui ākea o nā huahana i nā haukapila o US. Kekemapa 2021: Hoʻokumu ʻo Baxter i ka hui pū ʻana me ka mea hoʻolako ʻenehana lapaʻau US ʻo Hillrom. Ma o kēia hui pū ʻana, makemake nā ʻoihana ʻelua e hoʻohui i ʻelua mau ʻoihana ʻenehana lapaʻau nui e hoʻokō i kahi hihiʻo like o ka hoʻololi ʻana i ka mālama ola honua a me ka hoʻomaikaʻi ʻana i ka mālama maʻi. Mei 2021: Hoʻokumu ʻo Smiths Medical i ka hui pū ʻana me ka ʻoihana ʻenehana lapaʻau ʻo Ivenix. Ma o kēia hui pū ʻana, makemake nā ʻoihana ʻelua e hāʻawi i kahi ākea o nā hoʻonā hoʻokele infusion. Eia kekahi, e hāʻawi ʻo Smiths Medical i nā hoʻopukapuka hoʻolālā i nā hui lōʻihi i hoʻolālā ʻia e hoʻololi i ka hoʻokele hui ʻana a hoʻonui i ke olakino o ka mea maʻi, ʻoiai e hoʻokō ana i nā pono o nā mea hoʻolako mālama ola. ʻApelila 2021: Ua hoʻomaka ʻo B. Braun Medical i kahi papahana hou, ʻo Peripheral Advantage, e hoʻomaikaʻi i ka ʻike o nā mea maʻi me ka hoʻōla intravenous peripheral. Hoʻohui ka papahana i ke alakaʻi lapaʻau, ka intuition i hoʻokele ʻia e ka ʻikepili, a me nā mea hana i hoʻomaikaʻi ʻia e hoʻoikaika i nā kahu hānai e hoʻokō i ka holomua mua a kōkua i ka pale ʻana i nā paʻakikī e pili ana me ka hoʻōla IV peripheral. Iulai 2019: Loaʻa iā Baxter ka ʻae ʻana o ka US Food and Drug Administration (FDA) no Myxredlin. ʻAe ka ʻae ʻana no ka insulin koke no ka hoʻokomo intravenous i nā haukapila a me nā ʻoihana koʻikoʻi ʻē aʻe nā hoʻonohonoho mālama a he ola lōʻihi o 30 mau lā a i ʻole 24 mau mahina ma ka mahana o ka lumi inā e hoʻokomo ʻia i loko o ka pahu kumu e hōʻoia i ka pale ʻana mai ka mālamalama. Nā Hōʻike: Na ka Mea Hoʻohana Hope • Nā Halemai • Nā Kikowaena ʻoki kino Ambulatory • Nā Keʻena Lapaʻau ma o ka Noi • Ka Hoʻokele Lāʻau Lapaʻau • Nā Huahana Koko • Nā Meaʻai a me nā Hoʻonā Buffer • Nā Kikowaena Hoʻolaha ma ke ʻAno • Nā Catheters Intravenous • Nā Pumps Infusion • Nā Needle Hypodermic • Nā Ports Implantable • ʻOkoʻa ma o ka ʻĀina • ʻAmelika ʻĀkau o USo Kanadao Mekiko Koena o ʻAmelika ʻĀkau • ʻEulopa Kelemānia o UKo Palani Rusia Sepania Italia o Koena o ʻEulopa • ʻĀsia Pākīpika Kina o Iapana India Korea Singapore Malaysia o Koena o ʻAsia Pākīpika • LAMEAo Palakila Argentina UAE Saudi Arabia ʻApelika Hema Nigeria LAMEA Koena ʻIke Hui • B. Braun Melsungen AG • Medtronic PLC • Terumo Corporation • Fresenius SE & Co. KGaA • Cardinal Health, Inc. • Pfizer, Inc. • Teleflex, Inc. • Baxter International, Inc. • Smiths Group PLC • AngioDynamics, Inc. Nā Hāʻawi Kūikawā • Nui Uhi ʻana • Nā Papa Mākeke Nui Loa a me ka ʻIkepili • Loaʻa ke Kumu Hoʻohālike Kau Inoa • Kumukūʻai Maikaʻi Loa i Hōʻoia ʻia • Noiʻi Ma hope o ke Kūʻai Aku i Hōʻoia ʻia me ke Kākoʻo ʻia e 10% Hoʻopilikino E heluhelu i ka hōʻike piha no ka manuahi: https://www .reportlinker.com/p06283441/?utm_source=GNWAbout ReportlinkerʻO ReportLinker kahi hopena noiʻi mākeke lanakila. Loaʻa a hoʻonohonoho ʻo Reportlinker i ka ʻikepili ʻoihana hou loa i hiki iā ʻoe ke loaʻa koke i ka noiʻi mākeke āu e pono ai ma kahi hoʻokahi.______________________